General 2 — Longevity2020

Defining biological aging.jpg

Monday 27 April

5pm EU: 4pm UK: 11am EDT: 8am PDT

Defining biological aging

2.5 hours split over 3 sessions … Followed by ‘Ask me anything’ session for VIP ticket holders

Session 1

Phil Newman

Editor-In-Chief, Longevity.Technology

Introduction to a busy week for Longevity!

Attila Csordas

Founder & Director, AgeCurve Ltd

Towards a consensus definition of biological aging.

What are the differences between chronological and biological age and do we need a consensus definition? Will a consensus definition help us move towards Longevity?

George Church

Founding Core Faculty & Lead, Synthetic Biology, Wyss Institute at Harvard University

Reversal of several aging pathways & diseases

Nir Barzilai

Director, Institute for Aging Research

Leveraging aging science (geroscience) to improve older adults’ immune health

Lynne Cox

Associate Professor in Biochemistry, University of Oxford

Connections & differences between different hallmark processes (TBC)

Group discussion

All Session 1 speakers


5 minute coffee/bio break 🙂


Session 2

Steve Horvath

Professor of Human Genetics & Biostatistics, UCLA Fielding School of Public Health

Epigenetic clocks for clinical trials and preclinical research

Ludger Jansen

Professor of Philosophy, University of Rostock & University of Passau

Healthspan and aging: integrating operational definitions (in conjunction with Georg Fuellen, Professor of Biomedical Informatics, Rostock University Medical Center)

Richard Siow

Director, Longevity AI Consortium, Kings College, London

Longevity perspectives: from cell to society

Attila Csordas

Founder & Director, AgeCurve Ltd

Aging is agings: a recursive definition of biological aging


5 minute coffee/bio break 🙂


Session 3

Michael Fossel

Founder & President, Telocyte

Reversing human ageing: where are we really?

Brian Kennedy

Distinguished Professor of Biochemistry and Physiology, NUS, Singapore

Aging interventions from mice to humans

Aubrey de Grey

Founder and CEO, SENS Foundation

Defining aging concretely can clarify how to defeat it

Attila Csordas

Founder & Director, AgeCurve Ltd

Group discussion leader

Phil Newman

Editor-In-Chief, Longevity.Technology

Close and introduction to ‘Ask Me Anything’ session for VIP ticket holders


Please note: speakers, presentation titles and running order may change. This page is updated daily. Thanks.

Ask Me Anything

For VIP ticket holders only

A closed session with delegates and a selection of key speakers to address questions from the day and other key questions.